T1	Participants 67 73	adults
T2	Participants 284 332	Adults at moderate and high risk for skin cancer
T3	Participants 351 417	primary health care settings in Honolulu, HI, and Long Island, NY.
T4	Participants 796 837	A total of 596 adults completed the trial
